In a paper published March 4 in Nature Communications, coauthored by Lincoln Shenje, M.D., Ph.D, assistant professor at the OHSU Knight Cardiovascular Institute, researchers describe the first found gene mutation in humans that causes heart muscle cells to proliferate beyond birth. This mutation was discovered in a rare syndrome called ALMS1 that has been reported in less than 70 people in the past 50 years worldwide. According to Dr. Shenje and colleagues, this discovery goes … Read More
Posts Tagged ‘OHSU Knight Cardiovascular Institute’
The Fluidigm Corporation will be presenting on their single-cell genomics technology; an overview of the field of single-cell genomics and examples of applications on Friday, November 8 from 10 to 11 a.m. in Mac Hall 3189. This technology is currently deployed in the lab of Dr. Lincoln Shenje of the Knight Cardiovascular Institute. This research capability is made possible by the generous donation from the Knight Family, and this is one of the numerous ways in … Read More
Last week, Albert Starr, M.D., and Sanjiv Kaul, M.D., co-directors of the new OHSU Knight Cardiovascular Institute, published a letter to update the OHSU community on the progress of the institute. Included in this update is a discussion of potential “signature research themes” for the Knight Cardiovascular Institute. We encourage you to read the full letter in the School of Medicine Research Voice.
In September we announced a historic $125 million gift from Phil and Penny Knight to establish a new cardiovascular institute at OHSU. This week, the institute was officially named the OHSU Knight Cardiovascular Institute. Under the leadership of Albert Starr, M.D. and Sanjiv Kaul, M.D., the institute will aim to be a world leader in translational cardiovascular research. This gift comes four years after the creation of the OHSU Knight Cancer Institute, which thanks to … Read More